These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23818444)

  • 1. Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome.
    Widera C; Pencina MJ; Bobadilla M; Reimann I; Guba-Quint A; Marquardt I; Bethmann K; Korf-Klingebiel M; Kempf T; Lichtinghagen R; Katus HA; Giannitsis E; Wollert KC
    Clin Chem; 2013 Oct; 59(10):1497-505. PubMed ID: 23818444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
    Widera C; Pencina MJ; Meisner A; Kempf T; Bethmann K; Marquardt I; Katus HA; Giannitsis E; Wollert KC
    Eur Heart J; 2012 May; 33(9):1095-104. PubMed ID: 22199121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
    Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
    Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
    Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes.
    Georgiopoulos G; Kraler S; Mueller-Hennessen M; Delialis D; Mavraganis G; Sopova K; Wenzl FA; Räber L; Biener M; Stähli BE; Maneta E; Spray L; Iglesias JF; Coelho-Lima J; Tual-Chalot S; Muller O; Mach F; Frey N; Duerschmied D; Langer HF; Katus H; Roffi M; Camici GG; Mueller C; Giannitsis E; Spyridopoulos I; Lüscher TF; Stellos K; Stamatelopoulos K
    JAMA Cardiol; 2023 Oct; 8(10):946-956. PubMed ID: 37647046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.
    Poldervaart JM; Röttger E; Dekker MS; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; van 't Hof AW; Mosterd A; Hoes AW
    PLoS One; 2015; 10(7):e0132000. PubMed ID: 26177390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
    Liu WX; Zhao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic performance of kinetic changes of high-sensitivity troponin T in acute coronary syndrome and in patients with increased troponin without acute coronary syndrome.
    Mueller M; Biener M; Vafaie M; Blankenberg S; White HD; Katus HA; Giannitsis E
    Int J Cardiol; 2014 Jul; 174(3):524-9. PubMed ID: 24814895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of sex- and age-specific cutpoints for high-sensitivity Troponin T in non-ST-elevation acute coronary syndrome.
    Widera C; Giannitsis E; Mueller-Hennessen M; Reimann I; Guba-Quint A; Marquardt I; Bethmann K; Meyer S
    Int J Cardiol; 2019 Jan; 275():13-19. PubMed ID: 30352705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
    Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional value of B-type natriuretic peptide on discrimination of patients at risk for mortality after a non-ST-segment elevation acute coronary syndrome.
    García-Alvarez A; Regueiro A; Hernández J; Kasa G; Sitges M; Bosch X; Heras M
    Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):132-40. PubMed ID: 24448752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
    Klingenberg R; Aghlmandi S; Räber L; Akhmedov A; Gencer B; Carballo D; Nanchen D; Bucher HC; Rodondi N; Mach F; Windecker S; Landmesser U; von Eckardstein A; Hamm CW; Lüscher TF; Matter CM
    J Am Heart Assoc; 2021 Oct; 10(20):e020488. PubMed ID: 34622666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome.
    Bohula May EA; Bonaca MP; Jarolim P; Antman EM; Braunwald E; Giugliano RP; Newby LK; Sabatine MS; Morrow DA
    Clin Chem; 2014 Jan; 60(1):158-64. PubMed ID: 24052087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome.
    Mueller M; Biener M; Vafaie M; Doerr S; Keller T; Blankenberg S; Katus HA; Giannitsis E
    Clin Chem; 2012 Jan; 58(1):209-18. PubMed ID: 22134520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.
    Stamatelopoulos K; Mueller-Hennessen M; Georgiopoulos G; Sachse M; Boeddinghaus J; Sopova K; Gatsiou A; Amrhein C; Biener M; Vafaie M; Athanasouli F; Stakos D; Pateras K; Twerenbold R; Badertscher P; Nestelberger T; Dimmeler S; Katus HA; Zeiher AM; Mueller C; Giannitsis E; Stellos K
    Ann Intern Med; 2018 Jun; 168(12):855-865. PubMed ID: 29799975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes.
    Corsini A; Vagnarelli F; Bugani G; Bacchi Reggiani ML; Semprini F; Nanni S; Cinti L; Norscini G; Vannini A; Beltrandi E; Cavazza M; Branzi A; Rapezzi C; Melandri G
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):148-57. PubMed ID: 25124535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era.
    Onda T; Inoue K; Suwa S; Nishizaki Y; Kasai T; Kimura Y; Fukuda K; Okai I; Fujiwara Y; Matsuoka J; Sumiyoshi M; Daida H
    Int J Cardiol; 2016 Sep; 219():180-5. PubMed ID: 27327504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.